Agile Therapeutics Inc (AGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,779 | -28,304 | -28,741 | -30,335 | -16,077 |
| Depreciation Amortization | 23 | 23 | 19 | 18 | 12 |
| Other Working Capital | -1,022 | -454 | 1,284 | 138 | 264 |
| Other Operating Activity | 3,883 | 4,175 | 4,137 | 4,701 | 1,298 |
| Operating Cash Flow | $-16,895 | $-24,560 | $-23,301 | $-25,478 | $-14,503 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -318 | -1,313 | -31 | -290 | -96 |
| Investing Cash Flow | $-318 | $-1,313 | $-31 | $-290 | $-96 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 16,265 | 3,000 |
| Debt Repayment | -10,888 | -5,612 | 0 | -15,784 | N/A |
| Common Stock Issued | 0 | 18,687 | 37,862 | 19,923 | 49,811 |
| Other Financing Activity | 0 | 0 | -175 | -423 | -150 |
| Financing Cash Flow | $-10,888 | $13,075 | $37,687 | $19,981 | $52,661 |
| Beginning Cash Position | 35,952 | 48,750 | 34,395 | 40,182 | 2,120 |
| End Cash Position | 7,851 | 35,952 | 48,750 | 34,395 | 40,182 |
| Net Cash Flow | $-28,101 | $-12,798 | $14,355 | $-5,787 | $38,062 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,895 | -24,560 | -23,301 | -25,478 | -14,503 |
| Capital Expenditure | -318 | -1,313 | -31 | -290 | -96 |
| Free Cash Flow | -17,213 | -25,873 | -23,332 | -25,768 | -14,599 |